Perflubron

CHEMBL1200866 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
499.0 g/mol
LogP
6.9
Phase
4

A perfluorocarbon liquid used as a partial liquid ventilation agent in premature infants with severe respiratory distress syndrome, and investigated as an oxygen-carrying blood substitute. It dissolves large quantities of oxygen and carbon dioxide, allowing gas exchange in fluid-filled lungs.

Khối lượng phân tử

498,9600 g/mol

LogP

6,90

TPSA

0,00 Ų

Lipinski RO5

Không đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br

InChI

InChI=1S/C8BrF17/c9-7(22,23)5(18,19)3(14,15)1(10,11)2(12,13)4(16,17)6(20,21)8(24,25)26

Molecular Formula

C8BrF17

HBD / HBA

- / 17

Liên kết có thể quay

6

Nguyên tử nặng

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A perfluorocarbon liquid used as a partial liquid ventilation agent in premature infants with severe respiratory distress syndrome, and investigated as an oxygen-carrying blood substitute. It dissolves large quantities of oxygen and carbon dioxide, allowing gas exchange in fluid-filled lungs.

Yes, Perflubron is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200866. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9873. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.